All
Genomic Profiling Study Brings Personalized Medicine to Metastatic Bladder Cancer Patients
September 24th 2015The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder cancer study. The Hoosier Cancer Research Network (HCRN) will act as the coordinating center.
Molecular Subtype Proves to Be Prognostic Factor in Newly Diagnosed Gliomas
September 16th 2015This reanalysis confirmed that there is no difference for a radiotherapy-first versus a chemotherapy-first strategy in this setting, but there is a major difference in long-term outcomes for molecular stratification independent of treatment.